(Image Credits: Pixabay ... Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region.

Experimental drugs make a notable contribution to how much and how quickly each of these Big Pharma players ... While Merck shares are significantly below the VWAP, there is also an unclosed ...

Merck is planning layoffs in Pennsylvania as part of a multi-year plan to wind down operations at a manufacturing plant in the state. The pharma giant will cut 163 jobs at its Cherokee ...

Leaders at Merck & Co. Inc. are facing a new derivative shareholder lawsuit over allegations that they made misleading ...

Daily Merck & Company, Inc. Dow pharmaceutical components are leading overall index losses. Merck emerged as the biggest decliner, down 4.6%, while Amgen shed 4.3% and Johnson & Johnson lost 4.1%.

Under the agreement, Hengrui Pharma has granted Merck exclusive rights to develop, manufacture, and commercialize HRS-5346 worldwide, excluding the Greater China region. Hengrui Pharma will ...

Merck MRK announced that it has entered into an exclusive licensing deal with China-based Jiangsu Hengrui Pharmaceuticals (Hengrui Pharma) for the latter’s investigational oral small-molecule ...

AstraZeneca has signed two deals worth $1.35 billion with Alteogen to develop subcutaneous versions of the British pharma’s cancer drugs despite a potential patent infringement risk. Monday, AZ ...

Last year Merck agreed a similar licensing deal, also worth $2 billion, for Chinese biotech Hansoh Pharma’s experimental oral obesity drug, while yesterday Denmark’s Novo Nordisk (NVO ...

a TGF-beta-targeting PAH drug Merck acquired via its $11.5 billion takeover of Acceleron Pharma last year. Sotatercept is in phase 3 testing as an add-on therapy for PAH, and according to Merck ...

ESSA Pharma Inc. (NASDAQ:EPIX – Get Free Report) (TSE:EPI) passed below its 50-day moving average during trading on Wednesday .The stock has a 50-day moving average of $1.66 and traded as low as ...

Elon Musk’s AI company, xAI, has added image generation capabilities to its API. Only one model is available in the API at the moment, “grok-2-image-1212.” Given a caption, the model can ...